LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "cetrorelix" as a keyword



The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study

Sign Up to like & get
recommendations! Published in 2019 at "Archives of Gynecology and Obstetrics"

DOI: 10.1007/s00404-019-05163-3

Abstract: PurposeOvarian hyperstimulation syndrome (OHSS) is a serious complication of assisted reproductive technology (ART) treatment. However, there are limited data regarding the ability of the luteal GnRH antagonist cetrorelix to reduce the incidence of moderate and… read more here.

Keywords: group; cetrorelix; moderate; severe ohss ... See more keywords

P-713 Dose-dependent effects of ovulation inhibitors, chlormadinone acetate and cetrorelix, on serum endocrine profiles during ovarian stimulation: A retrospective Poisson regression analysis

Sign Up to like & get
recommendations! Published in 2025 at "Human Reproduction"

DOI: 10.1093/humrep/deaf097.1019

Abstract: How do the dose-dependent effects of chlormadinone acetate (CMA) and cetrorelix influence serum endocrine profiles in normal ovarian reserve patients undergoing controlled ovarian stimulation (COS)? Multivariable Poisson regression analysis revealed a significant dose-dependent effect of… read more here.

Keywords: analysis; ovulation inhibitors; dose dependent; cetrorelix ... See more keywords

Intranasal Delivery of Cetrorelix Via Lipid Liquid Crystal Nanoparticles: Characterization and Pharmacokinetic Studies in Rats

Sign Up to like & get
recommendations! Published in 2025 at "AAPS PharmSciTech"

DOI: 10.1208/s12249-025-03169-6

Abstract: Nasal sprays are extensively researched due to their rapid absorption, high bioavailability, and low side effects. Lipid liquid crystal nanoparticles (LLCNs) are being considered as potential carriers for intranasal delivery. LLCs loaded with cetrorelix (GnRH… read more here.

Keywords: formulation; brain; delivery; administration ... See more keywords

Combination treatment of recombinant growth differentiation factor-9 and Cetrorelix improves gestational origin of the polycystic ovarian syndrome in female rats.

Sign Up to like & get
recommendations! Published in 2023 at "Life sciences"

DOI: 10.2139/ssrn.4355248

Abstract: AIMS Polycystic ovary syndrome (PCOS) is a hyper-androgenic endocrinopathy prevalent in premenopausal women with no cure available. The current study aimed to investigate the therapeutic effect of recombinant GDF-9 and Cetrorelix on the gestational origin… read more here.

Keywords: gestational origin; syndrome; combination treatment; treatment ... See more keywords